Literature DB >> 30946300

Nurse-Led Telephone Advice Line for Patients With Inflammatory Bowel Disease: A Cross-Sectional Multicenter Activity Analysis.

Ester Navarro Correal1, Olga Benítez Leiva, Angelina Dosal Galguera, Marta Gallego Barrero, Elena Sánchez Pastor, M Francisca Murciano Gonzalo.   

Abstract

Telephone helplines is an effective method for helping patients with chronic diseases, including inflammatory bowel disease (IBD). The objective of this cross-sectional multicenter study was to assess reasons for consultation by patients with IBD to a nurse-led telephone service. The sample included 7,273 IBD patients from 6 public hospitals in Barcelona, Spain. Data collected included calls registered during 50 working days including caller characteristics, reason for consultation, patient's diagnosis, and action recommended. The most common reasons for consultation were suspicion of relapse, doubts regarding medication, drug monitoring, side effects, visit appointment, and request of test results. In 63.7% of cases, telephone calls were solved solely by nurses, and in 35.9% in collaboration with a physician. Patient's questions were resolved via telephone in 89.3%. Findings from this study add support of the nurse's role for providing an effective telephone service for resolution of a wide range of patient queries in IBD. Helplines managed by IBD nurses may be a key element for patient-centered care.

Entities:  

Mesh:

Year:  2019        PMID: 30946300     DOI: 10.1097/SGA.0000000000000372

Source DB:  PubMed          Journal:  Gastroenterol Nurs        ISSN: 1042-895X            Impact factor:   0.978


  2 in total

1.  Patients' Access to Telephone and E-mail Services Provided by IBD Nurses in Canada.

Authors:  Usha Chauhan; Larry Stitt; Noelle Rohatinsky; Melanie Watson; Barbara Currie; Lisa Westin; Wendy McCaw; Christine Norton; Irina Nistor
Journal:  J Can Assoc Gastroenterol       Date:  2021-10-21

2.  Effectiveness of a Telephone-Based Motivational Intervention for Smoking Cessation in Patients With Crohn Disease: A Randomized, Open-Label, Controlled Clinical Trial.

Authors:  Ester Navarro Correal; Francesc Casellas Jorda; Natalia Borruel Sainz; Virginia Robles Alonso; Claudia Herrera de Guise; Arantxa Ibarz Casas; Josep Maria Sánchez García; Genoveva Vila Morte; Carmen Fuentelsaz Gallego
Journal:  Gastroenterol Nurs       Date:  2021 Nov-Dec 01       Impact factor: 0.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.